Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BMMNCs in Mental Retardation
NCT01908400Phase 2Unknown
- Sponsor
- Chaitanya Hospital
- Start
- Sep 2014
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in intellectual disability (ID), sponsored by Chaitanya Hospital. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
intellectual disability (ID)
Beyond the preview
Go deeper on NCT01908400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908400.